Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Shengbang Pharmaceutical is a specialized pharmaceutical and biochemical manufacturer based in Qingdao, China. Founded in 1998, the company focuses on the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms, with a particular emphasis on joint health and biochemical products. Its core portfolio includes chondroitin sulfate, glucosamine salts, hyaluronic acid, and heparin sodium, which are supplied to the global pharmaceutical and nutraceutical industries. The company operates GMP-certified manufacturing facilities and maintains a significant export presence in markets across North America, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Shengbang Pharmaceutical.